Ethan Caldwell
Endocrinology Editor
Endocrinology & Hormonal Research
NovaEvum Research Editorial
Education
- Physiology, University of Toronto
- Endocrinology, Yale University
Ethan Caldwell covers endocrinology and hormone signalling for NovaEvum Research Editorial.
This specialization examines endocrine pathways, growth hormone physiology, receptor interactions and metabolic regulation.
Articles examine experimental findings involving peptide-related hormonal mechanisms and explain the differences between biological hypotheses and established clinical evidence. Articles examine peer-reviewed research from institutions, including Yale University, the University of Pennsylvania and other centres of endocrine research.
Topics covered
- Tesamorelin
- Ipamorelin
- CJC-1295
- Growth hormone
- IGF-1
- Endocrine receptors
Research categories
University references in NovaEvum Research Editorial describe institutions whose published scientific literature may be examined in our editorial coverage. These references do not imply that NovaEvum or its authors are affiliated with, endorsed by, or collaborating with those institutions.
25 articles under this name
IllustrationGrowth hormone peptides11 min readGhrelin receptor (GHSR1a) explained: discovery, constant signalling and the compounds studied at itThe ghrelin receptor was cloned before its hormone was known. How GHSR1a was found, why it signals with nothing bound, and which compounds…Read article
IllustrationGrowth hormone peptides11 min readGrowth hormone secretagogues explained: GHRH analogues, ghrelin agonists and what is approvedGrowth hormone secretagogues act at one of two pituitary receptors. Which molecules act where, what each literature measured, and which are…Read article
IllustrationKisspeptin-1010 min readThe HPG axis and kisspeptin explained: GnRH pulses, LH and FSH, and the receptor that starts pubertyHow the hypothalamic–pituitary–gonadal axis works, why GnRH must pulse, how kisspeptin was found to sit above it, and how LH and FSH are…Read article
IllustrationGrowth hormone peptides9 min readIpamorelin vs GHRP-6 and GHRP-2: what the selectivity data measured, and in which speciesIpamorelin's selectivity over GHRP-6 and GHRP-2 rests on one 1998 swine study. What was measured for cortisol, prolactin and appetite, and…Read article
IllustrationKisspeptin-109 min readKisspeptin-10 vs kisspeptin-54: same receptor, different lengths, different literaturesKisspeptin-10 and kisspeptin-54 share a receptor and a C-terminal sequence but differ in half-life, and their human studies measured…Read article
IllustrationPT-141 and melanocortins10 min readMelanocortin receptors explained: MC1R to MC5R, POMC peptides and the drugs built on themFive melanocortin receptors, one precursor hormone. What MC1R to MC5R do in the research literature, and where PT-141, setmelanotide and…Read article
IllustrationPT-141 and melanocortins9 min readPT-141 vs Melanotan II: one atom apart, one approved, one under a Health Canada warningPT-141 (bremelanotide) differs from Melanotan II only at its C-terminus. Their receptor profiles, trial records and regulatory status…Read article
IllustrationTesamorelin9 min readSermorelin vs Tesamorelin: Two GHRH Analogues ComparedSermorelin vs tesamorelin: a 29-residue fragment and a modified 44-residue hormone, their trials, populations and very different approval…Read article
IllustrationTesamorelin9 min readTesamorelin research: the visceral fat trials, the liver fat trial, and what was approvedTesamorelin's phase 3 trials in HIV-associated abdominal fat, the liver fat trials, what happened on stopping, and its FDA and Health…Read article
IllustrationTesamorelin9 min readTesamorelin vs Ipamorelin: Two Receptors, Two Evidence BasesTesamorelin vs ipamorelin: a GHRH analogue with one approved indication and a ghrelin-receptor agonist approved nowhere, compared on human…Read article
IllustrationGrowth hormone peptides9 min readWhat Is CJC-1295? DAC, No DAC and Which Molecule the Papers StudiedCJC-1295 names two GHRH analogues: one binds albumin and lasts days, one lasts minutes. Their structures, the trial record, and why neither…Read article
IllustrationGrowth hormone peptides9 min readWhat Is Ipamorelin? Structure, Receptor, Evidence and Regulatory StatusIpamorelin is a synthetic five-residue ghrelin-receptor agonist from Novo Nordisk. Its structure, mechanism, human record and why it is…Read article
IllustrationKisspeptin-109 min readWhat Is Kisspeptin-10? The Decapeptide, Its Receptor and the Human StudiesKisspeptin-10 is the shortest fully active kisspeptin, a ten-residue peptide that acts at KISS1R above GnRH. Its origin, human studies and…Read article
IllustrationPT-141 and melanocortins8 min readWhat Is PT-141? Bremelanotide, Vyleesi and the Melanocortin RecordPT-141 (bremelanotide) is a cyclic alpha-MSH analogue acting at central melanocortin receptors, FDA-approved as Vyleesi in 2019.Read article
IllustrationTesamorelin8 min readWhat Is Tesamorelin? The GHRH Analogue Behind EgriftaTesamorelin is a modified 44-residue GHRH analogue, approved as Egrifta for one HIV indication. Its structure, mechanism, trials and what…Read article
IllustrationGrowth hormone peptides2 min readIpamorelin Half-Life and Selectivity: What the Evidence Actually MeasuresExplore ipamorelin receptor selectivity, hormone-response studies, pharmacokinetic claims and the gaps in human outcome evidence.Read article
IllustrationPT-141 and melanocortins2 min readMelanotan II in Canada: Mechanism, Clinical Evidence and Safety WarningsMelanotan II Canada research guide covering melanocortin signalling, evidence limits, safety concerns and Canadian regulations.Read article
IllustrationGrowth hormone peptides2 min readSermorelin and Geref: The History Behind a Discontinued Peptide DrugThe history of sermorelin and Geref: what was approved, why that matters and what discontinued drug status does not prove.Read article
IllustrationGrowth hormone peptides2 min readSermorelin vs CJC-1295: GHRH Analogues and the DAC QuestionSermorelin vs CJC-1295 explained: receptor signalling, molecular differences, half-life claims and limits of the research.Read article
IllustrationGrowth hormone peptides6 min readSermorelin and the GHRH pathway: the first 29 residues, and the analogues built from themSermorelin is GHRH(1-29), once an approved medicine and now discontinued. How it relates to CJC-1295 and tesamorelin, and what its…Read article
IllustrationGrowth hormone peptides8 min readCJC-1295 and ipamorelin: three molecules, two names, and which papers describe whatMost of the CJC-1295 trial literature concerns the DAC version, which is not what is sold as CJC-1295. Ipamorelin acts on a different…Read article
IllustrationGrowth hormone peptides7 min readIpamorelin and somatopause: a research hypothesis, not an established conditionSomatopause is a descriptive term for age-related GH decline, and whether it is pathology or adaptation is unsettled.Read article
IllustrationKisspeptin-107 min readKisspeptin-10: what the human neuroendocrine literature measuredKisspeptin-10 is a genuine neuroendocrine research tool. Its human literature is small, short, and measures hormones in blood.Read article
IllustrationPT-141 and melanocortins7 min readPT-141 and the melanocortin receptors: what the bremelanotide record statesBremelanotide is approved in the United States as Vyleesi for one narrow indication. Research-chemical PT-141 is not that medicine.Read article
IllustrationTesamorelin7 min readSourcing research tesamorelin in Canada: what a certificate of analysis does and does not tell youTesamorelin is approved as Egrifta, for one indication. Research-chemical material is not that medicine. How to read a COA, and what it…Read article
